Based in NYC, Redpin Therapeutics is advancing novel platform technologies that enable the non-invasive, targeted regulation of neuronal cell activity in the brain. Leveraging its technologies, Redpin aims to treat both neurological and psychiatric disorders that do not respond to current therapies.